XE-TNFαm2

N/A

Report date: 2023/05/23 14:03:59

Base Information

Drug NameXE-TNFαm2
Drug Alias NameXE-TNFαm2
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor α inhibitorsC-X-C motif chemokine receptor 4 antagonists
TargetsTumor necrosis factor αC-X-C motif chemokine receptor 4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Basic Medicine, Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Basic Medicine, Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A